β¨ Medicine Schedule
NEW ZEALAND GAZETTE
No. 35
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Arginine hydrochloride 5.0% in 500 mL | Solution for infusion, bottle | McGaw Biomed Limited, Point Chevalier, Auckland | |
| Desferrioxamine mesylate 500 mg | Powder for injection, vial | David Bull Laboratories Limited, Mulgrave North, Victoria, Australia | |
| Sodium fluoride 2.73% w/w | Gel, topical, bottle | Pascal Company Inc., Bellevue, Washington, United States of America | 60 Second Taste (Apple Cinnamon flavour) |
| Sodium fluoride 2.73% w/w | Gel, topical, bottle | Pascal Company Inc., Bellevue, Washington, United States of America | 60 Second Taste (Bubblegum flavour) |
| Sodium fluoride 2.73% w/w | Gel, topical, bottle | Pascal Company Inc., Bellevue, Washington, United States of America | 60 Second Taste (Grape flavour) |
| Sodium fluoride 2.73% w/w | Gel, topical, bottle | Pascal Company Inc., Bellevue, Washington, United States of America | 60 Second Taste (Mint flavour) |
| Sodium fluoride 2.73% w/w | Gel, topical, bottle | Pascal Company Inc., Bellevue, Washington, United States of America | 60 Second Taste (Orange Twist flavour) |
| Sodium fluoride 2.73% w/w | Gel, topical, bottle | Pascal Company Inc., Bellevue, Washington, United States of America | 60 Second Taste (Raspberry flavour) |
| Sodium fluoride 2.73% w/w | Gel, topical, bottle | Pascal Company Inc., Bellevue, Washington, United States of America | 60 Second Taste (Strawberry flavour) |
| Sodium fluoride 0.685%, stannous fluoride 1.64% | Solution, topical | Pascal Company Inc., Bellevue, Washington, United States of America | 60:60 Rinse (Bubblegum flavour) |
| Sodium fluoride 0.685%, stannous fluoride 1.64% | Solution, topical | Pascal Company Inc., Bellevue, Washington, United States of America | 60:60 Rinse (Mint flavour) |
| Sodium fluoride 0.685%, stannous fluoride 1.64% | Solution, topical | Pascal Company Inc., Bellevue, Washington, United States of America | 60:60 Rinse (Raspberry flavour) |
| Sodium bicarbonate 750 g, 1000 g | Powder, cartridge | Althin Medical AB., Ronneby, Sweden | Altracart II |
| Methadone hydrochloride 2 mg/mL in 100 mL, 200 mL, 500 mL | Solution, oral | McGaw Biomed Limited, Point Chevalier, Auckland | Biodone |
| Ispaghula husk 100% | Powder, oral, bottles (300 g, 450 g), sachets (6 g) | Konsyl Pharmaceuticals Inc., Easton, Maryland, United States of America | Konsyl (sugar and flavour free) |
| Ispaghula husk 28% | Powder, oral, bottles (538 g), sachets (12 g) | Konsyl Pharmaceuticals Inc., Easton, Maryland, United States of America | Konsyl Orange (sucrose) |
| Ispaghula husk 58.60% | Powder, oral, bottles (425 g), sachets (5.8 g) | Konsyl Pharmaceuticals Inc., Easton, Maryland, United States of America | Konsyl Orange (sugar free) |
| Ispaghula husk 52% | Powder, oral, bottles (325 g, 500 g), sachets (6.5 g) | Konsyl Pharmaceuticals Inc., Easton, Maryland, United States of America | Konsyl-D (flavour free) |
| D(+)galactose 999 mg, palmitic acid 1 mg and water for injection (diluent) | Granules, for suspension, vials; diluent, ampoules | Schering AG, Berlin, Germany | Levovist |
| Recombinant Factor VIIa (human) 1.2 mg, 2.4 mg, 4.8 mg | Powder for injection, vial | Novo Nordisk A/S, Gentofte, Denmark | NovoSeven |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1997, No 35
NZLII —
NZ Gazette 1997, No 35
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare11 April 1997
Medicines Act, New Medicines, Distribution